Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease

Adalimumab (ADA) is applied to induce remission in patients with Crohn's disease (CD) naïve to chimeric anti-tumor necrosis factor-α (anti-TNF-α), infliximab or patients with loss of response to scheduled maintenance infliximab. Adsorptive granulocyte and monocyte apheresis (GMA) depletes eleva...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ozeki, Keiji, Tanida, Satoshi, Mizoshita, Tsutomu, Tsukamoto, Hironobu, Ebi, Masahide, Mori, Yoshinori, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2012
Matèries:
Published online: December, 2012
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3551391/
https://ncbi.nlm.nih.gov/pubmed/23341799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000346312
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars